LivingGLP1
Study S002418

Enacting Active Survivorship: Implementation of Weight Management Strategies in Endometrial Cancer Survivors

ClinicalTrials.gov record

Registration

Registration
NCT06877572
Acronym
ECS Weight
Study type
OBSERVATIONAL
Status
ACTIVE_NOT_RECRUITING
Enrollment
50
Start
2025-03-25
Primary completion
2028-10
Lead sponsor
University of Kansas Medical Center
Conditions
Endometrial Cancer Survivors; Weight Management; Early Stage Endometrial Cancer
Interventions
BEHAVIORAL:Weight loss with pharmacotherapy; BEHAVIORAL:Weight loss without pharmacotherapy
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Percentage of participants referred to weight loss clinic who are able to start weight management medications [12 months]

Linked records (4)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0005203Glucagon-Like Peptide-1 Receptor Agonists
Collins L, StatPearls Publishing, Treasure Island (FL)
2024OtherPMID 31855395registry reference BACKGROUND:31855395
R0009197Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action.
Ussher JR, Nature reviews. Cardiology
2023Other trialPMID 36977782DOIregistry reference BACKGROUND:36977782
R0014836What Is Best for Weight Loss? A Comparative Review of the Safety and Efficacy of Bariatric Surgery Versus Glucagon-Like Peptide-1 Analogue.
Klair N, Cureus
2023Other trialPMID 37905277DOIregistry reference BACKGROUND:37905277
R0022207Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials.
Gao X, Frontiers in pharmacology
2022Systematic reviewPMID 36188627DOIregistry reference BACKGROUND:36188627